TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 46 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $13,396,000 | +4.6% | 13,832,000 | 0.0% | 0.03% | -18.8% |
Q1 2020 | $12,802,000 | -2.4% | 13,832,000 | 0.0% | 0.03% | +18.5% |
Q4 2019 | $13,112,000 | +4.7% | 13,832,000 | 0.0% | 0.03% | +8.0% |
Q3 2019 | $12,524,000 | -51.8% | 13,832,000 | -51.3% | 0.02% | -51.0% |
Q2 2019 | $25,968,000 | +85.3% | 28,400,000 | +86.8% | 0.05% | -7.3% |
Q1 2019 | $14,013,000 | +2.2% | 15,200,000 | 0.0% | 0.06% | -8.3% |
Q4 2018 | $13,718,000 | -3.5% | 15,200,000 | 0.0% | 0.06% | +15.4% |
Q3 2018 | $14,216,000 | +0.9% | 15,200,000 | 0.0% | 0.05% | -3.7% |
Q2 2018 | $14,089,000 | +5.8% | 15,200,000 | 0.0% | 0.05% | +1.9% |
Q1 2018 | $13,322,000 | -56.9% | 15,200,000 | -56.8% | 0.05% | -56.2% |
Q4 2017 | $30,888,000 | -13.9% | 35,200,000 | -11.6% | 0.12% | -21.9% |
Q3 2017 | $35,870,000 | -25.3% | 39,800,000 | -11.2% | 0.16% | -28.9% |
Q2 2017 | $48,048,000 | +11.9% | 44,800,000 | +12.0% | 0.22% | +12.4% |
Q1 2017 | $42,950,000 | -1.9% | 40,000,000 | 0.0% | 0.19% | -5.8% |
Q4 2016 | $43,800,000 | +8.0% | 40,000,000 | +17.6% | 0.21% | +15.7% |
Q3 2016 | $40,566,000 | +10.5% | 34,000,000 | +16.0% | 0.18% | +8.5% |
Q2 2016 | $36,717,000 | -3.7% | 29,300,000 | 0.0% | 0.16% | -4.1% |
Q1 2016 | $38,127,000 | -16.7% | 29,300,000 | 0.0% | 0.17% | -14.5% |
Q4 2015 | $45,745,000 | +34.9% | 29,300,000 | +17.2% | 0.20% | +43.9% |
Q3 2015 | $33,906,000 | -3.0% | 25,000,000 | 0.0% | 0.14% | -0.7% |
Q2 2015 | $34,938,000 | +18.0% | 25,000,000 | +25.0% | 0.14% | +14.8% |
Q1 2015 | $29,600,000 | – | 20,000,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|